Carlo Cervellati
39PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (39)
Sort by Publication Date:
|Mar 17, 2026
Why acetylcholinesterase inhibitors should be considered disease-modifying drugs for Alzheimer's disease?Giovanni Zuliani, Carlo Cervellati, Marco Zuin
|Jan 28, 2026
Myeloperoxidase (MPO) Enzymatic Activity, but Not Its Protein Concentration, Is Associated with the Risk of Type 2 Diabetes in Females, Regardless of Obesity Status.Alessandro Trentini, Raffaella Riccetti, Domenico Sergi
|Oct 29, 2025
Effect of Dietary PUFAs and Antioxidants on Antioxidant and Anti-Inflammatory Functions of HDL in a Cohort of Women.Gianmarco Mola, Raffaella Riccetti, Domenico Sergi
|Apr 14, 2025
Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases-2nd Edition.Carlo Cervellati, Judit Marsillach
|Jan 19, 2025
Serum β-secretase 1 (sBACE1) activity in subjective cognitive decline: an exploratory study.Carlo Cervellati, Alessandro Trentini, Valentina Rosta
|Jan 09, 2025
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer's Disease.Carlo Cervellati, Alessandro Trentini, Marco Zuin
Pageof 7
Frequent Collaborators
18 joint publications
Alessandro Trentini
6 joint publications
Giuseppe Valacchi
6 joint publications
Judit Marsillach
5 joint publications
Angelina Passaro
4 joint publications
Domenico Sergi
4 joint publications
Veronica Tisato
3 joint publications
Maria Cristina Manfrinato
3 joint publications
Giovanni Zuliani
3 joint publications
Marco Zuin
3 joint publications
Carlo Contini
